Aurobindo Pharma receives Rs 70 crores ARV supply contract by NACO

[Guest guest]

Aurobindo Pharma receives Rs 70 crores ARV supply contract by NACO

Aurobindo Pharma Limited is pleased to inform that the company has

been awarded ARV contract worth Rs 70 crores for 3 products which are

WHO / USFDA pre-qualified by National Aids Control Organization

(NACO).

United Nations Office for Project Services (UNOPS), an NGO

established by United Nations to act as procurement agent for and on

behalf of the Ministry of Health , Government of India had called for

the tender for the supply of ARV drugs, the funding for which is done

by a global fund.

About Aurobindo Pharma Limited:

Aurobindo Pharma Limited (www.aurobindo.com), headquartered at

Hyderabad, India, manufactures generic pharmaceuticals and active

pharmaceutical ingredients. The company's manufacturing facilities

are approved by several leading regulatory agencies like US FDA, UK

MHRA, WHO, Health Canada, MCC South Africa. The company's robust

product portfolio is spread over 6 major therapeutic/product areas

encompassing Antibiotics, Anti-Retrovirals, CVS, CNS,

Gastroenterologicals, and Anti-Allergics. The Company is marketing

these products globally, in over 100 countries.

For further information, please contact:

Investor Relations

Aurobindo Pharma Limited

Reg Off: Plot No. 2, Maitrivihar

Ameerpeth, Hyderabad

Phone: 040-66725000 / 66725401

Email: ir@...